030 IMPLEMENTING OA TREATMENT RECOMMENDATIONS IN PRIMARY CARE POSTPONED JOINT REPLACEMENT IN HIP AND KNEE JOINTS - 8 YEAR FOLLOW-UP OF A CLUSTER RANDOMIZED CONTROLLED TRIAL
(2024)
Presentation / Conference
Østerås, N., Moseng, T., van Bodegom-Vos, L., Dziedzic, K. S., Natvig, B., Røtterud, J. H., …Hagen, K. B. (2024, April). 030 IMPLEMENTING OA TREATMENT RECOMMENDATIONS IN PRIMARY CARE POSTPONED JOINT REPLACEMENT IN HIP AND KNEE JOINTS - 8 YEAR FOLLOW-UP OF A CLUSTER RANDOMIZED CONTROLLED TRIAL. Presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria
Outputs (7)
306 Barriers and enablers to the implementation of osteoarthritis management programmes in primary or community care settings: a systematic review and qualitative framework synthesis (2024)
Presentation / Conference
Cunningham, J. C., Briggs, A. M., Cottrell, E., Doyle, F., Dziedzic, K., Finney, A., …French, H. (2024, April). 306 Barriers and enablers to the implementation of osteoarthritis management programmes in primary or community care settings: a systematic review and qualitative framework synthesis. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria
463 Metacarpophalangeal joint radiographic osteoarthritis: prevalence, distribution and association with potential risk factors (2024)
Presentation / Conference
Marshall, M., Nicholls, E., Jansen, V., Myers, H., Dziedzic, K. S., & van der Windt, D. (2024, April). 463 Metacarpophalangeal joint radiographic osteoarthritis: prevalence, distribution and association with potential risk factors. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria
767 EXPLORING THE POTENTIAL EXTENDED ROLE OF COMMUNITY PHARMACY IN THE MANAGEMENT OF OSTEOARTHRITIS: SURVEYS AND INTERVIEWS WITH COMMUNITY PHARMACY STAFF AND OTHER HEALTHCARE PROFESSIONALS (2024)
Presentation / Conference
Simkins, J., Holden, M., Babatunde, O. O., White, S., Nicholls, E., Long, A., …O'Brien, N. (2024, April). 767 EXPLORING THE POTENTIAL EXTENDED ROLE OF COMMUNITY PHARMACY IN THE MANAGEMENT OF OSTEOARTHRITIS: SURVEYS AND INTERVIEWS WITH COMMUNITY PHARMACY STAFF AND OTHER HEALTHCARE PROFESSIONALS. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria
768 STAKEHOLDER CO-DESIGN OF AN EXTENDED COMMUNITY PHARMACY ROLE AND SERVICE DELIVERY MODEL FOR PROVIDING OSTEOARTHRITS CARE: THE PHARMOA MODEL (2024)
Presentation / Conference
Holden, M., Stanford, C., Simkins, J., Babatunde, O. O., White, S., O'Brien, N., …Healey, E. L. (2024, April). 768 STAKEHOLDER CO-DESIGN OF AN EXTENDED COMMUNITY PHARMACY ROLE AND SERVICE DELIVERY MODEL FOR PROVIDING OSTEOARTHRITS CARE: THE PHARMOA MODEL. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria
775 BRACING ACCEPTABILITY AND ADHERENCE FOR KNEE OSTEOARTHRITIS: FINDINGS FROM A QUALITATIVE STUDY IN THE PROP-OA MULTICENTRE TRIAL (2024)
Presentation / Conference
Jinks, C., Holden, M., Asaname, E., Bullock, L., Herron, D., Halliday, N., …Peat, G. (2024, April). 775 BRACING ACCEPTABILITY AND ADHERENCE FOR KNEE OSTEOARTHRITIS: FINDINGS FROM A QUALITATIVE STUDY IN THE PROP-OA MULTICENTRE TRIAL. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria
818 NEITHER ANALYSIS APPROACH NOR RISK OF BIAS EXPLAIN THE LIMITED OVERALL BENEFIT OF THERAPEUTIC EXERCISE FOR KNEE AND/OR HIP OSTEOARTHRITIS IN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS (2024)
Presentation / Conference
Runhaar, J., Holden, M., Hattle, M., Quicke, J., Healey, E. L., van der Windt, D., …Foster, N. (2024, April). 818 NEITHER ANALYSIS APPROACH NOR RISK OF BIAS EXPLAIN THE LIMITED OVERALL BENEFIT OF THERAPEUTIC EXERCISE FOR KNEE AND/OR HIP OSTEOARTHRITIS IN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS. Poster presented at 2024 OARSI World Congress on Osteoarthritis, Vienna, Austria